CGM in Early Gestational Diabetes Improved Outcomes

Secondary outcomes favored CGM, including fewer preterm births and neonatal intensive care unit admissions.

1

Continuous glucose monitoring (CGM) did not improve time in range but enhanced maternal and neonatal outcomes in gestational diabetes.
2

CGM group had fewer preterm births (7% vs 18%) and lower cesarean delivery rates (20% vs 44%) compared to the control group.
3

Neonatal outcomes favored CGM, with fewer large-for-gestational-age births (5% vs 18%) and lower NICU admissions (23% vs 45%).
4

Patients using CGM reported high satisfaction, with a mean benefit score of 4.3 out of 5, indicating improved understanding of glucose management.
5

The study had limitations, including a single-center design and potential underpowering, but still highlighted CGM's benefits in managing gestational diabetes.

1